Overexpression of TRAF6 occurs in HSPCs from MDS patients, and correspondingly, hematopoietic-specific TRAF6 overexpression in mice results in an MDS-like phenotype [18, 38]. Here, TRAF6 is linked to myelodysplastic syndrome.